Skip to main content

Management of Legal Risks Associated with the Treatment of Retinopathy of Prematurity

  • Chapter
Retinopathy of Prematurity

Abstract

You have been called in by a neonatologist to consult and to assist in the care of a premature infant with a birth weight of 1200 g. Your task is to help preserve the infant’s vision while efforts are made to save the infant’s life. Using your professional skills and experience, you do help. Despite your efforts the infant develops retinopathy of prematurity (ROP). You are now a defendant in a lawsuit on behalf of a blind baby. You ask your lawyer to evaluate the chance that you will lose this suit, and you are told that the risks are large indeed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown DR, Miller JR, Ripepi UJ, Biglan AW. Retinopathy of prematurity risk factors in a five-year cohort of critically ill premature neonates. Am J Dis Child 1987; 141: 154–160.

    PubMed  CAS  Google Scholar 

  2. Brown DR, Biglan AW, Stretaysky M. Screening criteria for the detection of retinopathy of prematurity in patients in a neonatal intensive care unit. J Pediatr Ophthalmol Strabismus 1987; 24: 212–214.

    PubMed  CAS  Google Scholar 

  3. Luna B, Dobson V, Carpenter NA, Biglan AW. Visual field development in infants with stage 3 retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1989; 30: 580.

    PubMed  CAS  Google Scholar 

  4. Luna B, Dobson V, Biglan AW. Development of grating acuity in infants with regressed stage 3 retinopathy of prematurity. Invest Ophthalmol Vis Sci 1990; 31: 2082.

    Google Scholar 

  5. Tasman W, Brown GC. Progressive visual loss in adults with retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 1989; 222: 309.

    Article  Google Scholar 

  6. Charles SC, Runge PE. New instrumentation and pars plana vitrectomy techniques. In Ai E, Freweman WR, eds. Ophthalmology Clinics of North America. Philadelphia: Saunders, 1990: 517–531.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Simonds, M. (1992). Management of Legal Risks Associated with the Treatment of Retinopathy of Prematurity. In: Flynn, J.T., Tasman, W. (eds) Retinopathy of Prematurity. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2808-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2808-0_14

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7679-1

  • Online ISBN: 978-1-4612-2808-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics